Selected article for: "case definition and clinical case definition"
Author: Rasmuson, J.; Andersson, C.; Norrman, E.; Haney, M.; Evander, M.; Ahlm, C.
Title: Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus
  • Cord-id: ikq38rm1
  • Document date: 2011_1_15
    • ID: ikq38rm1
    Snippet: Hantaviruses have previously been recognised to cause two separate syndromes: hemorrhagic fever with renal syndrome in Eurasia, and hantavirus pulmonary syndrome (HPS) in the Americas. However, increasing evidence suggests that this dichotomy is no longer fruitful when recognising human hantavirus disease and understanding the pathogenesis. Herein are presented three cases of severe European Puumala hantavirus infection that meet the HPS case definition. The clinical and pathological findings we
    Document: Hantaviruses have previously been recognised to cause two separate syndromes: hemorrhagic fever with renal syndrome in Eurasia, and hantavirus pulmonary syndrome (HPS) in the Americas. However, increasing evidence suggests that this dichotomy is no longer fruitful when recognising human hantavirus disease and understanding the pathogenesis. Herein are presented three cases of severe European Puumala hantavirus infection that meet the HPS case definition. The clinical and pathological findings were similar to those found in American hantavirus patients. Consequently, hantavirus infection should be considered as a cause of acute respiratory distress in all endemic areas worldwide.

    Search related documents:
    Co phrase search for related documents
    • active treatment and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • active treatment and acute onset: 1, 2
    • active treatment and acute phase: 1, 2, 3, 4
    • active treatment and acute respiratory distress: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • active treatment and additional case: 1, 2
    • active treatment and admission day: 1, 2, 3
    • active treatment and admission prior: 1, 2, 3, 4, 5
    • active treatment and admission time: 1, 2
    • active treatment and lung involvement: 1, 2, 3, 4, 5
    • active treatment and lung tissue: 1, 2, 3
    • active treatment and lymphocyte response: 1